Saudi Pharmaceutical Journal最新文献

筛选
英文 中文
The association between uncontrolled hyperglycemia (Type-2 Diabetes) and cardiovascular sequelae in patients with and without insulin 有胰岛素和无胰岛素患者中未受控制的高血糖(2 型糖尿病)与心血管后遗症之间的关系
IF 3 3区 医学
Saudi Pharmaceutical Journal Pub Date : 2024-09-04 DOI: 10.1016/j.jsps.2024.102168
Sultan Alghadeer , Abdullah M. Mubarak , Bashayr Alsuwayni , Faisal Almurdhi , Hazim Almalki , Metib Alotaibi
{"title":"The association between uncontrolled hyperglycemia (Type-2 Diabetes) and cardiovascular sequelae in patients with and without insulin","authors":"Sultan Alghadeer ,&nbsp;Abdullah M. Mubarak ,&nbsp;Bashayr Alsuwayni ,&nbsp;Faisal Almurdhi ,&nbsp;Hazim Almalki ,&nbsp;Metib Alotaibi","doi":"10.1016/j.jsps.2024.102168","DOIUrl":"10.1016/j.jsps.2024.102168","url":null,"abstract":"<div><h3>Introduction</h3><p>Despite the availability of new cardio-protective oral hypoglycemic drugs, insulin is often recommended as an add-on therapy for type-2 diabetes with hemoglobin A1C (HbA1C) ≥ 9. Introducing insulin as a choice for patients with uncontrolled hyperglycemia (HbA1C≥9) has been questionably associated with cardiovascular sequelae. This study aims to examine the association between insulin use and cardiovascular effects in type-2 diabetic patients with uncontrolled hyperglycemia.</p></div><div><h3>Methodology</h3><p>A retrospective observational cohort study was conducted to identify cardiovascular complications between the two groups (patients with HbA1C≥9% on insulin versus those with HbA1C≥9% without insulin) at King Saud University Medical City (KSUMC). Patients with type-2 diabetes whose HbA1C was ≥ 9 during the period from 2015 to 2018 and who were followed up within the hospital for at least 5 years until the end of 2022 were included in the study.</p></div><div><h3>Results</h3><p>A total of 366 patients were included in the study; 286 patients were on insulin, while 80 patients were not. The median baseline HbA1C levels were comparable between the two groups (10.2 versus 9.8). After 5 years of follow-up, there was no significant difference between the groups (29.4 % of insulin users versus 18.8 % of non-insulin users; p = 0.065). However, the incidence of other diabetes complications, such as retinopathy, nephropathy, and neuropathy, was significantly higher among patients who were on insulin compared to those not on insulin (50.7 % versus 27.5 %; p = 0.005). Additionally, the average of the last three HbA1C readings and the overall average HbA1C readings were significantly higher among patients who were on insulin (9.67 % versus 9.07 %; p = 0.001) compared to those not on insulin (9.64 % versus 9.11 %; p = 0.005).</p></div><div><h3>Conclusion</h3><p>Our study did not find a significant association between the use of insulin and cardiovascular complications. The association between insulin therapy and the development of other diabetes complications warrants further investigation.</p></div>","PeriodicalId":49257,"journal":{"name":"Saudi Pharmaceutical Journal","volume":"32 10","pages":"Article 102168"},"PeriodicalIF":3.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1319016424002184/pdfft?md5=009719cf703073428eebbac1c5c4b243&pid=1-s2.0-S1319016424002184-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142150191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phytochemical, biological, and nutritional properties of the prickly pear, Opuntia dillenii: A review 刺梨的植物化学、生物和营养特性:综述
IF 3 3区 医学
Saudi Pharmaceutical Journal Pub Date : 2024-08-30 DOI: 10.1016/j.jsps.2024.102167
EL Hassania Loukili , Mohammed Merzouki , Mohamed Taibi , Amine Elbouzidi , Belkheir Hammouti , Krishna Kumar Yadav , Mohammad Khalid , Mohamed Addi , Mohammed Ramdani , Pankaj Kumar , Jeong Ryeol Choi
{"title":"Phytochemical, biological, and nutritional properties of the prickly pear, Opuntia dillenii: A review","authors":"EL Hassania Loukili ,&nbsp;Mohammed Merzouki ,&nbsp;Mohamed Taibi ,&nbsp;Amine Elbouzidi ,&nbsp;Belkheir Hammouti ,&nbsp;Krishna Kumar Yadav ,&nbsp;Mohammad Khalid ,&nbsp;Mohamed Addi ,&nbsp;Mohammed Ramdani ,&nbsp;Pankaj Kumar ,&nbsp;Jeong Ryeol Choi","doi":"10.1016/j.jsps.2024.102167","DOIUrl":"10.1016/j.jsps.2024.102167","url":null,"abstract":"<div><p>Opuntia (Cactaceae) species are native to arid and semi-arid regions of Mexico and the southern United States and grow in various climatic zones. <em>Opuntia dillenii</em> is a cactus fruit with many beneficial properties, and it is used as a medicinal plant in various countries. This review paper provides updated information on the phytochemical and pharmacological aspects of <em>O. dillenii</em>. The fruit contains valuable compounds such as flavonoids, phenolics, ascorbic acid, betanin, and essential elements, which have been isolated and identified. The fruit also exhibits diverse pharmacological activities, such as antioxidant, anti-inflammatory, anti-tumor, neuroprotective, hepatoprotective, hypotensive, anti-diabetic, antifungal, and anticancer effects. Moreover, molecular docking and ADMET predictions were performed to evaluate the antibacterial potential of the fruit against <em>Escherichia coli</em> protein. This paper suggests that <em>O. dillenii</em> has significant potential as a complementary therapy for various pathological conditions.</p></div>","PeriodicalId":49257,"journal":{"name":"Saudi Pharmaceutical Journal","volume":"32 10","pages":"Article 102167"},"PeriodicalIF":3.0,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1319016424002172/pdfft?md5=ee4bbdb85497ccd13bc58d07a3f0d8e0&pid=1-s2.0-S1319016424002172-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142097671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and patterns of sleep-related melatonin usage among adults in Saudi Arabia: A self-reported cross-sectional national study 沙特阿拉伯成年人使用与睡眠有关的褪黑激素的普遍程度和模式:一项自我报告的全国性横断面研究
IF 3 3区 医学
Saudi Pharmaceutical Journal Pub Date : 2024-08-26 DOI: 10.1016/j.jsps.2024.102166
Yousef D. Alqurashi , Mohammed Alhaddad , Amar Albahrani , Ali Alfajri , Ahmed Abdulwahab , Hussain Albahrani , Abdullah Alhajri , Saad Alshareef , Sulaiman S. Alsaif , Khalid AlHarkan , Michael I. Polkey
{"title":"Prevalence and patterns of sleep-related melatonin usage among adults in Saudi Arabia: A self-reported cross-sectional national study","authors":"Yousef D. Alqurashi ,&nbsp;Mohammed Alhaddad ,&nbsp;Amar Albahrani ,&nbsp;Ali Alfajri ,&nbsp;Ahmed Abdulwahab ,&nbsp;Hussain Albahrani ,&nbsp;Abdullah Alhajri ,&nbsp;Saad Alshareef ,&nbsp;Sulaiman S. Alsaif ,&nbsp;Khalid AlHarkan ,&nbsp;Michael I. Polkey","doi":"10.1016/j.jsps.2024.102166","DOIUrl":"10.1016/j.jsps.2024.102166","url":null,"abstract":"<div><h3>Purpose</h3><p>Despite the surge of melatonin supplement consumption in recent years, data on the prevalence and patterns of melatonin usage in Saudi Arabia is lacking. The aim of this study was to assess the prevalence and pattern of sleep-related melatonin usage among adults in Saudi Arabia.</p></div><div><h3>Methods</h3><p>This was a cross-sectional, web-based, self-administered survey study conducted across all regions of Saudi Arabia. Participants were recruited from the general population (≥18 years). The survey was distributed between February and April 2023. Chi-squared tests and t-tests were performed for comparative bivariate analyses where binary logistic regression was performed to derive the main predictors of melatonin consumption.</p></div><div><h3>Results</h3><p>Out of 5,606 participants, 536 (10 %) were consumers of melatonin. Older age (Adjusted OR = 1.01, 95 % CI = 1.01–1.02, p = 0.002), being a male (Adjusted OR = 1.76, 95 % CI = 1.46–2.14, p = 0.001), individuals with a doctorate degree or an equivalent (adjusted OR 2.37 95 % CI = 1.35–4.17, p = 0.003), perceived poor sleep quality (Adjusted OR = 1.52, 95 % CI = 1.10–2.11, p = 0.01), and being diagnosed with a sleep disorder (Adjusted OR = 2.55, 95 % CI = 2.04–3.18, p = 0.001) were all associated with increased likelihood of sleep-related melatonin usage. 35 % of consumers self-reported taking ≥1 tablet per day, while 26 % of them were uncertain about the dosage they consume.</p></div><div><h3>Conclusion</h3><p>With a notable prevalence of 10% among the general population in Saudi Arabia, melatonin usage was more common in older adults, males, and those with higher education.</p></div>","PeriodicalId":49257,"journal":{"name":"Saudi Pharmaceutical Journal","volume":"32 10","pages":"Article 102166"},"PeriodicalIF":3.0,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1319016424002160/pdfft?md5=41c52ad2f80d9a27ea578fc417e10491&pid=1-s2.0-S1319016424002160-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142150284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between self-reported antipsychotics side effects and depression in Saudi Arabia 沙特阿拉伯人自我报告的抗精神病药物副作用与抑郁症之间的关系
IF 3 3区 医学
Saudi Pharmaceutical Journal Pub Date : 2024-08-20 DOI: 10.1016/j.jsps.2024.102164
Yazed AlRuthia
{"title":"The relationship between self-reported antipsychotics side effects and depression in Saudi Arabia","authors":"Yazed AlRuthia","doi":"10.1016/j.jsps.2024.102164","DOIUrl":"10.1016/j.jsps.2024.102164","url":null,"abstract":"<div><h3>Background</h3><p>The utilization rate of antipsychotics to treat different mental disorders is rising. However, little is known about their side effects’ impact on depression levels. Therefore, the objective of this study was to examine the association between antipsychotic side effects and depression among psychiatric patients treated with antipsychotics.</p></div><div><h3>Methods</h3><p>This is a prospective, single-center, interview-based, cross-sectional study that examined the association between antipsychotic side effects and depression among adult patients (e.g., ≥18 yrs.) with psychiatric illnesses (e.g., depression, schizophrenia, bipolar disorder) visiting outpatient clinics in a university-affiliated tertiary care center. Antipsychotic side effects were assessed using the Arabic version of the Glasgow Antipsychotic Side-effect Scale (GASS), while depression was assessed using the Arabic version of the 9-item Patient Health Questionnaire (PHQ-9). Univariate and multiple linear regressions were conducted to examine the association between the PHQ-9 and GASS scores.</p></div><div><h3>Results</h3><p>One hundred patients met the inclusion criteria and consented to participate. Most of the patients were females (72 %) with a mean age of 38 years. Schizophrenia (37 %) and bipolar disorder (54 %) were the most common mental disorders among the recruited patients. The majority of patients were treated with atypical (e.g., second-generation) antipsychotics (88 %) for at least six months (74 %). Controlling for age, gender, annual family income, education, employment status, marital status, number of comorbidities, duration of treatment with antipsychotics, the type of antipsychotic, and psychiatric illness, higher GASS scores, which indicate more severe antipsychotic side effects, predicted higher PHQ-9 score (e.g., higher levels of depression) (β = 0.419, 95 % CI=[0.307–0.532], <em>p</em>-value &lt; 0.0001).</p></div><div><h3>Conclusion</h3><p>Early identification and management of antipsychotic side effects among psychiatric patients should enhance patient adherence and improve treatment outcomes. Future studies should verify the findings of this study using more robust study designs.</p></div>","PeriodicalId":49257,"journal":{"name":"Saudi Pharmaceutical Journal","volume":"32 10","pages":"Article 102164"},"PeriodicalIF":3.0,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1319016424002147/pdfft?md5=ad3342f96f85b5648c17ab6a3b278c86&pid=1-s2.0-S1319016424002147-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142047965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substance misuse disorder in Saudi Arabia: A comprehensive examination of current demographic patterns, trends, and intervention requirements 沙特阿拉伯的药物滥用障碍:对当前人口模式、趋势和干预要求的全面审查
IF 3 3区 医学
Saudi Pharmaceutical Journal Pub Date : 2024-08-16 DOI: 10.1016/j.jsps.2024.102163
Mansour Tobaiqy , Ahmed I. Al-Asmari
{"title":"Substance misuse disorder in Saudi Arabia: A comprehensive examination of current demographic patterns, trends, and intervention requirements","authors":"Mansour Tobaiqy ,&nbsp;Ahmed I. Al-Asmari","doi":"10.1016/j.jsps.2024.102163","DOIUrl":"10.1016/j.jsps.2024.102163","url":null,"abstract":"<div><h3>Introduction</h3><p>This review examines substance misuse disorder (SMD) in Saudi Arabia, drawing insights from 43 prior studies. It explores the prevalence and patterns of SMD across diverse demographics.</p></div><div><h3>Methodology</h3><p>Our analysis integrated data from various studies involving adolescents, university students, psychiatric patients, and the general population as well as postmortem cases. It identifies key risk factors and challenges in managing SMD, underscoring the importance of comprehensive data collection for evidence-based policymaking.</p></div><div><h3>Results</h3><p>SMD in Saudi Arabia were categorized into two groups: common traditionally abused drugs (such as Captagon, khat, heroin, ethanol, and cannabis) and substances that have emerged in recent years (e.g., methamphetamine “Shabu”, pregabalin, and benzodiazepines). Trends in SMD include early substance initiation and increased amphetamine and polysubstance use.</p></div><div><h3>Conclusion and recommendations</h3><p>Drug-related challenges persist in Saudi Arabia; however, because of limited data from recent epidemiological studies on drug disorders, the full extent is unknown. Saudi Arabia is unique because it as an Islamic country with strict regulations against drug trafficking and a religious prohibition on drugs and alcohol, which contributes to distinct trends in substance misuse disorder (SMD). Although some aspects mirror global patterns, others exhibit regional characteristics specific to the country. Despite data variability, actionable recommendations have emerged for SMD prevention and treatment. During the COVID-19 pandemic, a high number of reports was evident; however, SMD publications often reiterate old findings and overlook emerging psychoactive substances (EPS), such as ‘Shabu”, pregabalin, and benzodiazepines. Further studies are needed, including educational initiatives, national surveys, stricter drug regulations, and an early warning system for traditional SMD and EPS.</p></div>","PeriodicalId":49257,"journal":{"name":"Saudi Pharmaceutical Journal","volume":"32 10","pages":"Article 102163"},"PeriodicalIF":3.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1319016424002135/pdfft?md5=7ae87f98003b4244b6e635938fbcd02e&pid=1-s2.0-S1319016424002135-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142047964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mannosylated PAMAM G2 dendrimers mediated rate programmed delivery of efavirenz target HIV viral latency at reservoirs 由甘露糖基化 PAMAM G2 树状分子介导的依非韦伦按速率编程递送,靶向储库中的艾滋病毒病毒潜伏期
IF 3 3区 医学
Saudi Pharmaceutical Journal Pub Date : 2024-08-13 DOI: 10.1016/j.jsps.2024.102154
Rohini Kharwade , Mohsin Kazi , Nilesh Mahajan , Payal Badole , Sachin More , Asaad Kayali , Md Noushad Javed , Mohammed Kaleem
{"title":"Mannosylated PAMAM G2 dendrimers mediated rate programmed delivery of efavirenz target HIV viral latency at reservoirs","authors":"Rohini Kharwade ,&nbsp;Mohsin Kazi ,&nbsp;Nilesh Mahajan ,&nbsp;Payal Badole ,&nbsp;Sachin More ,&nbsp;Asaad Kayali ,&nbsp;Md Noushad Javed ,&nbsp;Mohammed Kaleem","doi":"10.1016/j.jsps.2024.102154","DOIUrl":"10.1016/j.jsps.2024.102154","url":null,"abstract":"<div><p>In this current research, we conceptualized a novel nanotechnology-enabled synthesis approach of targeting HIV-harboring tissues via second-generation (G2) polyamidoamine (PAMAM) mannosylated (MPG2) dendrimers for programmed delivery of anti-HIV drugs efavirenz (EFV) and ritonavir (RTV). Briefly, here mannose served purpose of ligand in this EFV and RTV-loaded PAMAM G2 dendrimers, synthesized by divergent techniques, denoted as MPG2ER. The developed nanocarriers were characterized by different analytical tools FTIR, NMR, zeta potential, particle size, and surface morphology. The results of confocal microscopy showed substantial alterations in the morphology of H9 cells, favored by relatively higher drug uptake through the MPG2ER. Interestingly, the drug uptake study and cytotoxicity assay of MPG2ER demonstrated that it showed no significant toxicity up to 12.5 µM. A typical flow cytometry histogram also revealed that MPG2ER efficiently internalized both drugs, with an increase in drug uptake of up to 81.2 %. It also enhanced the plasma pharmacokinetics of EFV, with C<sub>max</sub>7.68 μg/ml, AUC of 149.19 (μg/ml) * hr, and MRT of 26.87 hrs. Subsequently, tissue pharmacokinetics further evidence that MPG2ER accumulated more in distant Human immunodeficiency virus (HIV) reservoir tissues, such as the lymph nodes and spleen, but without exhibiting significant toxicity. Abovementioned compelling evidences strongly favored translational roles of MPG2 as a potential therapeutic strategy in the clinical eradication of HIV from viral reservoir tissue.</p></div>","PeriodicalId":49257,"journal":{"name":"Saudi Pharmaceutical Journal","volume":"32 10","pages":"Article 102154"},"PeriodicalIF":3.0,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1319016424002044/pdfft?md5=1d333bdd0035c0470fc640fb1d81987a&pid=1-s2.0-S1319016424002044-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142088356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating topical delivery of erythromycin laden into lipid nanocarrier for enhancing the anti-bacterial activity 研究通过脂质纳米载体局部递送红霉素以增强抗菌活性
IF 3 3区 医学
Saudi Pharmaceutical Journal Pub Date : 2024-07-28 DOI: 10.1016/j.jsps.2024.102152
Heba S. Elsewedy , Sultan Alshehri , Naheda S. Alsammak , Nada F. Abou Chahin , Manal S. Alotaibi , Rehab A. Alshammari , Tamer M. Shehata , Bandar Aldhubiab , Wafaa E. Soliman
{"title":"Investigating topical delivery of erythromycin laden into lipid nanocarrier for enhancing the anti-bacterial activity","authors":"Heba S. Elsewedy ,&nbsp;Sultan Alshehri ,&nbsp;Naheda S. Alsammak ,&nbsp;Nada F. Abou Chahin ,&nbsp;Manal S. Alotaibi ,&nbsp;Rehab A. Alshammari ,&nbsp;Tamer M. Shehata ,&nbsp;Bandar Aldhubiab ,&nbsp;Wafaa E. Soliman","doi":"10.1016/j.jsps.2024.102152","DOIUrl":"10.1016/j.jsps.2024.102152","url":null,"abstract":"<div><p>Skin infections considered as one of the predominant disorders that could greatly influence humans. Topical drug delivery is believed to be an effective substitute to systemically delivered medication for skin disorders management. Erythromycin has been proven to retain anti-bacterial activity. Based on that, the aim of existent study is to develop a proper nanocarrier, namely; nanoemulsion using tea tree oil including Erythromycin. Applying quality by design approach, the optimized nanoemulsion was selected based on number of independent variables namely; particle size and <em>in vitro</em> release study. Yet, in order to get appropriate topical application, the optimized nanoemulsion was combined with previously prepared hydrogel base to provide Erythromycin based nanoemulgel. The developed nanoemulgel was assessed for its organoleptic and physical characters to ensure its suitability for topical application. Stability study was implemented over three months after being kept in two distinct environments. Eventually, the antibacterial behavior of the preparation was investigated on MRSA to verify the expected antibacterial improvement and validate the effectiveness of the developed nanocarrier. The formulation showed consistent appearance, with pH (6.11 ± 0.19), viscosity (10400 ± 1275 cP), spreadability (54.03 ± 2.3 mm), extrudability (80.36 ± 3.15 g/cm<sup>2</sup>) and drug content (99.3 ± 0.46 %) that seemed to be satisfied for topical application. It could provide 48.1 ± 4.2 % releases over 6 h in addition to be stable at room temperature and at refrigerator. Ultimately, the formula showed a significant antibacterial activity against MRSA proving the combination and the nanocarrier effectiveness.</p></div>","PeriodicalId":49257,"journal":{"name":"Saudi Pharmaceutical Journal","volume":"32 9","pages":"Article 102152"},"PeriodicalIF":3.0,"publicationDate":"2024-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1319016424002020/pdfft?md5=952b53410627b4f9a063d6a99ef42bec&pid=1-s2.0-S1319016424002020-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141850820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced anti-tumor therapy for hepatocellular carcinoma via sorafenib and KIAA1199-siRNA co-delivery liposomes 通过索拉非尼和 KIAA1199-siRNA 协同递送脂质体加强肝细胞癌的抗肿瘤治疗
IF 3 3区 医学
Saudi Pharmaceutical Journal Pub Date : 2024-07-28 DOI: 10.1016/j.jsps.2024.102153
Yao Yao , Qian Zhao , Feng Xu , Tingting Yao
{"title":"Enhanced anti-tumor therapy for hepatocellular carcinoma via sorafenib and KIAA1199-siRNA co-delivery liposomes","authors":"Yao Yao ,&nbsp;Qian Zhao ,&nbsp;Feng Xu ,&nbsp;Tingting Yao","doi":"10.1016/j.jsps.2024.102153","DOIUrl":"10.1016/j.jsps.2024.102153","url":null,"abstract":"<div><p>Hepatocellular carcinoma (HCC) is one of the most lethal malignancies worldwide. Sorafenib (Sf) is currently the first-line treatment for HCC. However, due to the side effects and unsatisfied efficiency of Sf, it is urgent to combine different therapeutic agents to inhibit HCC progression and increase the therapeutic efficacy. Here, our study constructed a Sf and KIAA1199-siRNA co-loaded liposome Sf-Lp-KIAA, which was prepared by electrostatic interaction of KIAA1199-siRNA and Sf loaded liposome (Sf-Lp). The particle size, zeta potential, the in vitro cumulative release was investigated. The physical and chemical properties were characterized, and the inhibition of HepG2 growth and metastasis in vitro was investigated. The cellular uptake of the co-loaded liposome was significantly higher than that of free siRNA, and the drug/siRNA could be co-delivered to the target cells. Sf-Lp-KIAA could significantly inhibit the growth, migration, invasion and down-regulate KIAA1199 expression of HepG2 cells in vitro than that of single Sf treated group. In addition, the co-delivery liposome accumulated in the HepG2 subcutaneous tumor model and suppress tumor growth after systemic administration without induce obvious toxicity. The present study implied that the co-delivery of Sf and KIAA1199-siRNA through the co-loaded liposomes exerted synergistic antitumor effects on HCC, which would lay a foundation for HCC therapy in the future.</p></div>","PeriodicalId":49257,"journal":{"name":"Saudi Pharmaceutical Journal","volume":"32 9","pages":"Article 102153"},"PeriodicalIF":3.0,"publicationDate":"2024-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1319016424002032/pdfft?md5=1330afed65f042a0816e5ca68999ef5e&pid=1-s2.0-S1319016424002032-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141846149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Closing the loop: Strengthening course quality of Pharm.D. program via applying a comprehensive four-step review approach 闭环:通过应用全面的四步审查法加强药学博士课程的质量
IF 3 3区 医学
Saudi Pharmaceutical Journal Pub Date : 2024-07-23 DOI: 10.1016/j.jsps.2024.102151
Lobna Aljuffali , Amjad Faihan BinLebdah , Rihaf Alfaraj , Dalal Alkhelb , Jawza F. Alsabhan , Ahmed Z. Alanazi , Khalid Alhazzani
{"title":"Closing the loop: Strengthening course quality of Pharm.D. program via applying a comprehensive four-step review approach","authors":"Lobna Aljuffali ,&nbsp;Amjad Faihan BinLebdah ,&nbsp;Rihaf Alfaraj ,&nbsp;Dalal Alkhelb ,&nbsp;Jawza F. Alsabhan ,&nbsp;Ahmed Z. Alanazi ,&nbsp;Khalid Alhazzani","doi":"10.1016/j.jsps.2024.102151","DOIUrl":"10.1016/j.jsps.2024.102151","url":null,"abstract":"<div><p>This study explores the course review process implemented by the College of Pharmacy at King Saud University for its Pharm.D. program. Through a qualitative research design, a dedicated course review committee was established to oversee the evaluation process. The committee gathered and analyzed data from various sources, including course reports, student evaluations, and exam center reports, to achieve a holistic understanding of each course’s effectiveness. The evaluation process was structured into a Four-Step Course Evaluation Approach: data collection, data review and recommendations, taking appropriate action, and communicating the outcomes. The “closing the loop” stage ensured that recommendations were effectively implemented, and course evaluation data were systematically archived for future reference. The results of this study, based on the evaluation of 25 courses, revealed significant improvements in course quality, alignment with program learning outcomes, and adherence to accreditation standards. Key findings included the identification of gaps and discrepancies, leading to targeted interventions and enhanced course content. Overall, this study highlights the effectiveness of a structured course review process in enhancing the quality of education and ensuring continuous improvement within the college. The committee focuses on refining evaluation criteria, conducting workshops, and providing training to stay current with emerging accreditation standards and best practices. This systematic course review process demonstrates the College’s commitment to providing high-quality education and preparing students for successful careers in pharmacy, with significant implications for the improvement of pharmacy education and the overall student learning experience.</p></div>","PeriodicalId":49257,"journal":{"name":"Saudi Pharmaceutical Journal","volume":"32 9","pages":"Article 102151"},"PeriodicalIF":3.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1319016424002019/pdfft?md5=f3ce18a8cfe7a433e00b35bb41aa57db&pid=1-s2.0-S1319016424002019-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141954500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ceftriaxone and MC-100093 mitigate fentanyl-induced cardiac injury in mice: Preclinical investigation of its underlying molecular mechanisms 头孢曲松和 MC-100093 可减轻芬太尼诱导的小鼠心脏损伤:对其潜在分子机制的临床前研究
IF 3 3区 医学
Saudi Pharmaceutical Journal Pub Date : 2024-07-21 DOI: 10.1016/j.jsps.2024.102148
Abdullah F. AlAsmari , Mohammed M. Alshehri , Nemat Ali , Fawaz AlAsmari , Youssef Sari , Wayne E. Childers , Magid Abou-Gharbia , Metab Alharbi , Doaa M. Elnagar , Wejdan S. AL-Qahtani
{"title":"Ceftriaxone and MC-100093 mitigate fentanyl-induced cardiac injury in mice: Preclinical investigation of its underlying molecular mechanisms","authors":"Abdullah F. AlAsmari ,&nbsp;Mohammed M. Alshehri ,&nbsp;Nemat Ali ,&nbsp;Fawaz AlAsmari ,&nbsp;Youssef Sari ,&nbsp;Wayne E. Childers ,&nbsp;Magid Abou-Gharbia ,&nbsp;Metab Alharbi ,&nbsp;Doaa M. Elnagar ,&nbsp;Wejdan S. AL-Qahtani","doi":"10.1016/j.jsps.2024.102148","DOIUrl":"10.1016/j.jsps.2024.102148","url":null,"abstract":"<div><p>Drug addiction is considered a worldwide concern and one of the most prevailing causes of death globally. Opioids are highly addictive drugs, and one of the most common opioids that is frequently used clinically is fentanyl. The potential harmful effects of chronic exposure to opioids on the heart are still to be elucidated. Although β-lactam antibiotics are well recognized for their ability to fight bacteria, its protective effect in the brain and liver has been reported. In this study, we hypothesize that β-lactam antibiotic, ceftriaxone, and the novel synthetic non-antibiotic β-lactam, MC-100093, are cardioprotective against fentanyl induced-cardiac injury by upregulating xCT expression. Mice were exposed to repeated low dose (0.05 mg/kg, i.p.) of fentanyl for one week and then challenged on day 9 with higher dose of fentanyl (1 mg/kg, i.p.). This study investigated cardiac histopathology and target genes and proteins in serum and cardiac tissues in mice exposed to fentanyl overdose and β-lactams. We revealed that fentanyl treatment induced cardiac damage as evidenced by elevated cardiac enzymes (troponin I). Furthermore, fentanyl treatment caused large aggregations of inflammatory cells and elevation in the areas and volumes of myocardial fibers, indicating hypertrophy and severe cardiac damage. Ceftriaxone and MC-100093 treatment, However, induced cardioprotective effects as evidenced by marked reduction in cardiac enzymes (troponin I) and changes in histopathology. Furthermore, ceftriaxone and MC-100093 treatment decreased the levels of hypertrophic genes (α-MHC &amp; β-MHC), apoptotic (caspase-3), and inflammatory markers (IL-6 &amp; NF-κB). This study reports for the first time the cardioprotective effect of β-lactams against fentanyl-induced cardiac injury. Further studies are greatly encouraged to completely identify the cardioprotective properties of ceftriaxone and MC-100093.</p></div>","PeriodicalId":49257,"journal":{"name":"Saudi Pharmaceutical Journal","volume":"32 9","pages":"Article 102148"},"PeriodicalIF":3.0,"publicationDate":"2024-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1319016424001981/pdfft?md5=3181f8429d815e4bff699a7b674f3bcc&pid=1-s2.0-S1319016424001981-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141847027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信